Clinical Trials Directory

Trials / Sponsors / Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Thyroid Eye Disease
Phase 32025-07-01
Active Not RecruitingA Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Thyroid Eye Disease (TED)
Phase 32025-02-03
Active Not RecruitingAn Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)
Thyroid Eye Disease
Phase 32024-08-27
Active Not RecruitingAn Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
Thyroid Eye Disease
Phase 32024-08-27
CompletedA Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (
Thyroid Eye Disease
Phase 32024-05-23
CompletedAn Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301
Thyroid Eye Disease
Phase 32024-01-31
CompletedAn Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye
Thyroid Eye Disease
Phase 32023-11-14
CompletedA Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With
Thyroid Eye Disease
Phase 32021-12-03